 |
09-09-2011, 08:35 AM
|
#1
|
|
Senior Member
Join Date: Sep 2005
Location: Alaska
Posts: 2,018
|
It Depends
Like DebL and Becky, I was diagnosed stage 1 and have stayed NED. I have only seen an onc when I have had questions -- such as when I was interested in a clinical trial for Tykerb as a preventative drug. My PCP has handled everything else, including prescribing whatever imaging or other testing like CA 15-3's that we agreed upon.
But had I been diagnosed at a higher stage, or if I had higher risk factors such as if I had been BRCA positive, for example, I might have chosen to see the onc a little more often.
So.... it depends.
A.A.
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
|
|
|
09-09-2011, 07:41 PM
|
#2
|
|
Senior Member
Join Date: Jul 2006
Posts: 463
|
Re: Scheduled Onc visits at 2nd Year of NED
Just to clarify (AA), I was stage 3a, definitely not early stage (I'll leave my signature below).
The way I saw it, the visits to my onc didn't offer protection, and they didn't offer solace. I liked to visit with him -- as we enjoyed somewhat-eclectic conversations about things like the benefits of exercise, and weight control, and looking our mortality in the face -- but he had no protection to offer me at those arbitrarily-timed visits. Indeed, "early" detection of mets offered little protection to me (brain mets excepted, and since I didn't get Herceptin, those were unlikely to be my first site of recurrence).
I knew what symptoms were concerning, and I did make special visits for a few of them. Later on, my PCP responded to a few concerns with appropriate f/u (an MRI for persistent migraines, and a BRCA referral for a new discovery of pancreatic cancer in a maternal cousin and 2 previously-hidden breast cancer diagnoses in maternal aunts). All those concerns proved to be groundless (negative MRI of brain, and no BRCA mutations found).
I am not saying that this (avoidance of medical encounters) is the right style for everyone. But I do think that it's a fine style for some of us. Vigilance and frequent testing may reassure some -- not a bad thing. But it probably will not affect the ultimate outcome, should we have a recurrence. If any one of us feels more protected by frequent onc visits and testing, then I am fine with that person pursuing those options. But it is also true that there is no evidence to support that style of care, and so for those of us who are more comfortable with fewer medical interactions, it is perfectly reasonable that we follow our gut, or instincts -- and inform ourselves of what symptoms are concerning and should be reported, while eschewing those arbitrary onc visits.
I'm curious if there are other on this forum who share my approach. My perception of the culture here is that "more is always better" is the majority-opinion. Which is fine. We are each the best person to make that call, for ourselves. I only post this evening to be sure that if there are others who might feel differently, they feel okay to express their opinion.
Debbie Laxague
__________________
3/01 ~ Age 49. Occult primary announced by large (6cm) axillary node, found by my husband.
4/01 ~ Bilateral mastectomies (LMRM, R elective simple) - 1.2cm IDC was found at pathology. 5 of 11 axillary nodes positive, largest = 6cm. Stage IIIA
ERPR 5%/1% (re-done later at Baylor, both negative at zero).
HER2neu positive by IHC and FISH (8.89).
Lymphovascular invasion, grade 3, 8/9 modified SBR.
TX: Control of arm of NSABP's B-31 adjuvant Herceptin trial (no Herceptin, inducing a severe case of Herceptin-envy): A/C x 4 and Taxol x 4 q3weeks, then rads. Raging infection of entire chest after small revision of mastectomy scar after completing tx (significance unknown). Arimidex for two years, stopped after second pathology opinion.
2017: Mild and manageable lymphedema and some cognitive issues.
|
|
|
09-09-2011, 09:09 PM
|
#3
|
|
Senior Member
Join Date: Sep 2005
Location: Alaska
Posts: 2,018
|
Re: Scheduled Onc visits at 2nd Year of NED
Hi Debbie. Thanks very much for posting the correction, and I am very sorry that it was necessary to spell it out. It was clearly my mistake, unintentional but not helpful on my part.
AlaskaAngel
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
|
|
|
| Thread Tools |
|
|
| Display Modes |
Hybrid Mode
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is Off
|
|
|
All times are GMT -7. The time now is 07:36 AM.
|